Immune status during albendazole therapy for hydatidosis.
Immunological monitoring of cystic hydatid patients undergoing medico-surgical management has revealed that it is possible to assess individual host responses throughout therapy and subsequently be guided by the results obtained. The analysis has involved the demonstration of variation in haemagglutination antibodies, specific IgG and IgM immunoglobulins and circulating immune complexes before, during, and months after albendazole therapy.
Matossian
R M
RM
Department of Microbiology, American University of Beirut, Lebanon.
Awar
G N
GN
Radwan
H
H
Craig
P S
PS
Meshefedjian
G A
GA
D000293:Adolescent; D000328:Adult; D015766:Albendazole / Q000627:therapeutic use*; D000818:Animals; D000909:Antibodies, Helminth / Q000378:metabolism; D000936:Antigen-Antibody Complex / Q000378:metabolism; D003131:Combined Modality Therapy; D004443:Echinococcosis / Q000188:drug therapy* / Q000276:immunology* / Q000601:surgery; D004446:Echinococcus / Q000276:immunology; D005260:Female; D006388:Hemagglutinins / Q000378:metabolism; D006801:Humans; D007074:Immunoglobulin G / Q000378:metabolism; D007075:Immunoglobulin M / Q000378:metabolism; D008297:Male; D008875:Middle Aged
D000909:Antibodies, Helminth; D000936:Antigen-Antibody Complex; D006388:Hemagglutinins; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D015766:Albendazole